Asia/Oceania Researchers Achieve Targeted A-to-G Base Editing in Human Mitochondrial DNA Premium The technology can in principle correct almost half of pathogenic mtDNA mutations, paving the way for mitochondrial disease modeling and therapeutic applications. Illumina, Precision Health Research Singapore Partner for 100K Genomes Population Study The initiative, called SG100K, plans to sequence and analyze the genomes of 100,000 Singaporeans to study Asian genomic diversity and Asian-specific diseases. SeekIn Gets CE Mark for Cancer Treatment Response Monitoring Kit The test monitors cancer treatment response through shallow whole-genome sequencing of ctDNA and protein analysis. Genes2Me Obtains CE Marking for Clinical Sequencing Panels The panels, which were designed and have been validated for several common NGS platforms, cover oncology, pharmacogenomics, and hereditary diseases. New Horizon Health, Prenetics to Launch Colorectal Cancer Test in Hong Kong, Macau, Taiwan The companies first agreed to jointly commercialize the stool-based DNA test, which was developed by New Horizon, in late 2019. May 18, 2022 Hong Kong Dx Firm Prenetics Shares Down 9 Percent on First Day on Nasdaq May 18, 2022 Avalon GloboCare, Lu Daopei Hematology Institute Partner to Develop Cell Therapy CDx May 17, 2022 New CRISPR Approach Enables Gene Editing in Cockroaches, Potentially Many Insect Species May 17, 2022 VolitionRx Bets on Canine Cancer Screening Test as Nucleosome Tech Development Continues Premium May 13, 2022 Type 2 Diabetes Multi-Ancestry GWAS Enables Risk Prediction Across Populations May 9, 2022 CNV-Adjusted Analysis Points to Prognostically Informative Meningioma Methylation Groups May 9, 2022 Hitachi High-Tech, Invivoscribe Partner on Cancer MDx Development May 9, 2022 Artemis DNA to Provide Datar Cancer Genetics Liquid Biopsy Tests in the US, Vietnam Under $250M Deal May 6, 2022 Illumina Provides Updates on China Business, Grail, Upcoming Sequencing Chemistries Premium May 5, 2022 BGI Fosters Adoption of Stereo-Seq Spatial Transcriptomics Technology Premium Apr 28, 2022 Genome Insight Raises $23M in Series B Funding Apr 27, 2022 Lupus Linked to TLR7 Mutations, Related Signaling Changes Apr 27, 2022 PetDx-led Team Clinically Validates Liquid Biopsy Test for Canine Cancers Apr 26, 2022 Genome Study Reveals Tibetan-Yi Corridor Population History, Relationships Apr 26, 2022 RootPath Brings Collaborators Into the Fold With Origami-Based Synthetic DNA Assembly Method Premium Apr 26, 2022 Alercell to Distribute Zeesan Biotech Leukemia Fusion Gene Test Kit Apr 26, 2022 ERS Genomics Licenses CRISPR-Cas9 IP to Sumitomo Pharma Apr 25, 2022 VolitionRx Signs on Sage Healthcare as Distributor for Canine Cancer Test in Asia Apr 22, 2022 Nutromics Eyes Clinical Applications for Electrochemical Continuous Molecular Monitoring Platform Premium Apr 22, 2022 Ancient DNA Points to Male-Dominated Megalith Monuments at Neolithic Normandy Site Load More Breaking News Canadian Healthcare Providers, Policymakers Value Different Aspects of Clinical Genomic Sequencing New Products Posted to GenomeWeb: Oxford Nanopore, Bio-Rad, NanoString, More People in the News at OraSure, Element Biosciences, Micronoma, More Guardant Health Files Motions to Dismiss, Change Venue in Illumina Patent Lawsuit In Brief This Week: SQI Diagnostics, T2 Biosystems, Enhanc3D, QuidelOrtho, More Illumina, Precision Health Research Singapore Partner for 100K Genomes Population Study The Scan Blend of Omicron With Delta The Associated Press reports that currently circulating Omicron variants have some features previously seen in the Delta variant. Limited Contrast The New York Times reports that there is a shortage of a contrast agent used for some medical scans. Pig Improvement Farmers in China are using genetics to improve their hog herds, according to Reuters. Science Papers Present Way to Molecularly Classify Prostate Cancer, Saliva-Based SARS-CoV-2 Test, More In Science this week: approach to molecularly classify prostate tumors, saliva-based test for SARS-CoV-2, and more.